Changes in Pediatric Emergency Department Visits During the COVID-19 Pandemic

Zaid Haddadin1, Anna Blozinski2, Kailee Fernandez2

  • 1Departments of Pediatrics and zaid.haddadin@vumc.org.

Hospital Pediatrics
|January 13, 2021
PubMed

Insights

Pediatric emergency department visits for respiratory illnesses declined during the pandemic, while trauma visits increased significantly. This shift highlights changes in injury patterns and the impact of public health measures on children's healthcare needs.

Area of Science:

  • Pediatric emergency medicine
  • Public health
  • Epidemiology

Background:

  • Community mitigation measures were implemented to reduce the spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
  • The impact of these measures on pediatric emergency department (ED) visits for acute respiratory illnesses (ARIs) and trauma is not fully understood.

Purpose of the Study:

  • To evaluate changes in pediatric ED visits for ARIs and trauma before and during the COVID-19 pandemic.
  • To hypothesize a decrease in ED visits and ARIs, with a concurrent increase in the proportion of trauma visits.

Main Methods:

  • Retrospective study analyzing pediatric ED visits (2018-2020) for ARI or trauma at a high-volume children's hospital.
  • Data collected between March and May annually.
  • International Classification of Diseases, 10th Revision, Clinical Modification (ICD-10-CM) codes used for diagnosis; Pearson's chi-squared test for statistical comparison.

Main Results:

  • Total pediatric ED visits decreased by 46% in 2020 compared to 2018-2019.
  • Acute respiratory illness visits declined by 58%, while trauma visits decreased by 34%.
  • The proportion of trauma visits significantly increased to over 25% of total ED visits in 2020, with a notable rise in recreational vehicle crashes.

Conclusions:

  • Pediatric ED visits decreased substantially during the pandemic, but the proportion of trauma-related visits increased significantly.
  • Injury mechanisms showed significant variation compared to pre-pandemic years.
  • Further research is needed to confirm these findings and inform strategies for reducing ARIs and specific types of trauma.
Abstract

Related Concept Videos

Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
109
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
108
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
131
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
106
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
89
Issues And Trends In Healthcare Delivery System01:29

Issues And Trends In Healthcare Delivery System

The issues and trends in healthcare delivery are constantly changing. The COVID-19 pandemic is one recent issue that wreaked havoc on healthcare systems, causing a shortage of healthcare workers, high demand for medicines and supplies, and increased medical expenditure due to a lack of insurance. Other issues include rising healthcare costs and care fragmentation.
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
6.0K